Wednesday, 24 May 2017

Generics News

  • US rheumatoid arthritis market to reach $9.3 bn by 2020'

    Generics |  Analysis | By BioSpectrum Bureau | 0 Comment

    Singapore: US treatment market for rheumatoid arthritis (RA) is set to increase in value from $6.4 billion in 2013 to $9.3 billion by 2020, representing a compound annual growth rate (CAGR)...Read more

  • BioSpectrum announces the hits and misses of 2013

    Generics |  Analysis | By BioSpectrum Bureau | 0 Comment

    Asia attracted a lot of interest from foreign multinational giants in the year 2013. This not only led to the increase in the number of acquisitions and mergers (M&A), it also led to a ...Read more

  • Teva proposes to buy Mylan for $40.1 billion

    Generics |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Israeli generic drug giant Teva pharmaceuticals made an unsolicited offer to buy US-based Mylan NV for about $40.1 billion, in the drug industry's largest takeover attempt this y...Read more

  • Teva's Potential $40 bn Mylan acquisition could transform generics space'

    Generics |  Analysis | By BioSpectrum Bureau | 0 Comment

    Singapore: Teva Pharmaceutical Industries' recent $40.1 billion offer to purchase Netherlands-based Mylan, which is crucially contingent on Mylan not consummating its offer to acquire Irish...Read more

  • TB claims 74000 children each year: WHO

    Generics |  Analysis | By BioSpectrum Bureau | 0 Comment

    Singapore: World Health Organization has launched "Roadmap for childhood TB: towards zero deaths", in an effort to prevent deaths of children from tuberculosis (TB) that claims nearly 74000...Read more

  • Boehringer, Lilly diabetes drug shows +ve results

    Generics |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Boehringer Ingelheim and Eli Lilly and Company have presented their results from two randomized phase III clinical trials evaluating the 'efficacy and safety of linagliptin in As...Read more

  • Indian drugmakers shifting R&D to South East Asia

    Generics |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Many leading Indian drug makers, that comprise a core part of the country's $1,000 bn worth pharmaceutical industry, are soon shifting their research and development operations a...Read more

  • Unlike FDA, Indian regulators finds no violations at Ranbaxy

    Generics |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: India's Drugs Controller General of India (DCGI) has said that under the country's Drugs and Cosmetics Act, it has found 'no major violations' at Ranbaxy's Mohali plant that has ...Read more

  • Pfizer, Hisun launch generics joint venture in China

    Generics |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Pfizer and China's Zhejiang Hisun Pharmaceuticals, a leading Chinese pharmaceutical company, announced the launch of Hisun-Pfizer Pharmaceuticals, a joint venture formed between ...Read more

  • Teva launches generic of Abilify, antipsychotic drug

    Generics |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Teva Pharmaceutical has launched the generic equivalent to Abilify, aripiprazole tablets, an atypical antipsychotic medication, are approved for the treatment of schizophrenia an...Read more

  • Sun's generic of Takeda ulcer drug gets FDA nod

    Generics |  Regulatory | By BioSpectrum Bureau | 0 Comment

    Singapore: Indian pharmaceutical major, Sun Pharmaceutical Industries announced that the generic version of Prevacid by the company has received that final approval from the US FDA. The Am...Read more

  • Teva to pay $718 mn to apex tax body in Israel

    Generics |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Israel-based Teva Pharmaceutical is going to pay $718 million to Israel Tax Authority to pay for the release of trapped profits, settling tax assessments for the years 2005-07 an...Read more

  • Sandoz gets FDA nod for MS generic drug

    Generics |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Sandoz, a Novartis company, has recieved USFDA approval of Glatopa, a first generic version of Teva's Copaxone (glatiramer acetate injection) for multiple sclerosis therapy. "Sa...Read more

  • Drug shortage forces FDA to approve cancer generic

    Generics |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: The US FDA has provided its approval for a generic version of cancer drug Doxil that has been facing shortage due to manufacturing deficiencies. This generic version of the drug...Read more

  • Hong Kong to host international TCM exhibition, conference

    Generics |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Hong Kong Trade Development Council (HKTDC) and Modernized Chinese Medicine International Association (MCMIA ) is organizing 12th International Conference and Exhibition of the M...Read more

  • Britain's MHRA recalls 16 Wockhardt medicines

    Generics |  Regulatory | By BioSpectrum Bureau | 0 Comment

    Singapore: UK's drug regulatory body, Medicines and Healthcare products Regulatory Agency (MHRA) has recalled 16 drugs manufactured by Wockhardt Ltd after identifying 'manufacturing deficie...Read more

  • Chinese planning agency to probe pharma prices

    Generics |  Regulatory | By BioSpectrum Bureau | 0 Comment

    Singapore: China's primary economic planning agency, the National Development and Reform Commission (NDRC) is in the process of investigating the costs and prices charged by drugmakers. Acc...Read more

  • Aurobindo recalls epilepsy drug lot in US

    Generics |  Regulatory | By BioSpectrum Bureau | 0 Comment

    Singapore: India-based Aurobindo Pharma in the US is recalling Gabapentin capsules, USP 300 mg 100-count bottles, at consumer level due to possible stashs of some empty capsules. USFDA has...Read more

Survey Box

Will biobanking change healthcare in the world?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls